印度喘的危险因素:全球喘网络 (GAN) 一期研究的结果
Sheetu Singh1, Sundeep Salvi2, Sushil K Kabra3
1Department of Pulmonary Medicine, Rajasthan Hospital, Jaipur, Rajasthan, India.
Lung India : official organ of Indian Chest Society
|June 26, 2025
概括
这项研究确定了印度儿童和成人喘的遗传,环境,个人健康和饮食风险因素. 需要采取公共卫生措施来改善空气质量,提高饮食意识,减少室内风险以预防喘.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 环境健康 环境健康
背景情况:
- 喘是一种严重的呼吸系统疾病,在全球范围内影响着各种年龄组.
- 识别特定的风险因素和触发因素对于有效的预防和管理策略至关重要,特别是在像印度这样多元化的人口中.
研究的目的:
- 评估印度儿童和成年人患喘的风险因素和触发因素.
- 分析全球喘网络第一阶段研究的数据,具体针对印度次大陆.
主要方法:
- 一个多中心,国际,基于学校,问卷驱动的横截面研究.
- 分析了2017-18年间从印度九个中心收集的数据,其中包括20084名儿童,25887名青少年和81296名成年人.
主要成果:
- 父母有喘病史,花粉热,暴露在潮湿的家中,使用抗生素,以及某些早期生命暴露与喘风险有关.
- 环境因素,如青少年的交通接近和物暴露,以及成年人的室内燃料是显著的.
- 青少年的饮食因素,如香,乳酪,包装零食和冰淋消费,以及成年人的蚊虫驱蚊剂使用显示出相关性.
结论:
- 这项研究强调了导致印度喘的遗传,环境,个人健康和饮食因素的结合.
- 强调有针对性的公共卫生干预措施的必要性,重点关注空气质量,饮食习惯和室内环境安全.
相关概念视频
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma: Pathogenesis and Management
573
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
573
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
446
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
446


